CD86 and coronary artery disorder: They found a downregulation of immature (CD1a+) DCs in ST-elevation myocardial infarction (STEMI), non-STEMI, and coronary artery disease (CAD) patients and an upregulation of mature (CD86+) DCs in CAD patients.